Gold homeopathic trading portfolio MT4

404

Unfortunately, Gold homeopathic trading portfolio MT4 signal is disabled and unavailable

Provider has disabled this signal. However, the huge database of other active signals and providers remains at your disposal. Select the most appropriate one, connect to it and let your terminal copy the trades automatically.

You can check out other signals of Ren Cheng Yao:

Growth
131%
Subscribers
1
Weeks
66
Trades
683
Win
74%
Profit Factor
3.07
Max DD
8%
Growth
41%
Subscribers
0
Weeks
18
Trades
158
Win
86%
Profit Factor
3.08
Max DD
40%
Growth
620%
Subscribers
0
Weeks
68
Trades
14522
Win
70%
Profit Factor
1.74
Max DD
16%
Growth
326%
Subscribers
0
Weeks
67
Trades
261
Win
50%
Profit Factor
1.99
Max DD
31%
Growth
42%
Subscribers
0
Weeks
8
Trades
1025
Win
64%
Profit Factor
1.64
Max DD
24%
Growth
50%
Subscribers
0
Weeks
10
Trades
7951
Win
72%
Profit Factor
1.70
Max DD
13%

Or select from other MetaTrader 4 signals:

Growth
4 459%
Subscribers
8
Weeks
231
Trades
3075
Win
73%
Profit Factor
1.79
Max DD
46%
Growth
1 364%
Subscribers
18
Weeks
40
Trades
699
Win
68%
Profit Factor
3.03
Max DD
16%
Growth
2 851%
Subscribers
36
Weeks
255
Trades
3413
Win
73%
Profit Factor
2.46
Max DD
43%
Growth
3 508%
Subscribers
33
Weeks
63
Trades
1350
Win
60%
Profit Factor
1.73
Max DD
40%
Growth
1 662%
Subscribers
13
Weeks
31
Trades
2707
Win
80%
Profit Factor
1.61
Max DD
41%
Growth
1 716%
Subscribers
9
Weeks
350
Trades
7843
Win
80%
Profit Factor
1.83
Max DD
27%
Growth
881%
Subscribers
9
Weeks
48
Trades
2891
Win
77%
Profit Factor
1.97
Max DD
21%
Growth
870%
Subscribers
15
Weeks
66
Trades
1457
Win
77%
Profit Factor
2.13
Max DD
46%
Growth
3 945%
Subscribers
32
Weeks
121
Trades
2746
Win
71%
Profit Factor
2.13
Max DD
42%
Growth
4 712%
Subscribers
107
Weeks
208
Trades
4268
Win
58%
Profit Factor
1.71
Max DD
54%

No suitable signals?
Select and subscribe
to one of 6149 available signals
for MetaTrader 4

Subscriber accepts all execution risks when subscribing to a signal. Historical statistics cannot guarantee any profitability in the future.